As of November 2024, Takeda Pharmaceutical Company has a market cap of $46.27B. This makes Takeda Pharmaceutical Company the world's 386th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $47.46B | 6.44% |
2023 | $44.59B | -1.39% |
2022 | $45.21B | 31.05% |
2021 | $34.50B | -16.46% |
2020 | $41.30B | -13.32% |
2019 | $47.64B | 16.92% |
2018 | $40.75B | -42.12% |
2017 | $70.40B | 32.39% |
2016 | $53.17B | -20.28% |
2015 | $66.70B | 21.38% |
2014 | $54.95B | 3.55% |
2013 | $53.06B | 25.16% |
2012 | $42.40B | 14.05% |
2011 | $37.17B | -15.39% |
2010 | $43.94B | 4.31% |
2009 | $42.12B | -17.46% |
2008 | $51.03B | -29.38% |
2007 | $72.26B | -19.58% |
2006 | $89.85B | 28.06% |
2005 | $70.17B | 23.64% |
2004 | $56.75B | 21.41% |
2003 | $46.74B | -14.31% |
2002 | $54.55B | -16.36% |
2001 | $65.22B | -12.28% |
2000 | $74.35B | - |